- ÀÛ¼ºÀÚ
- °ü¸®ÀÚ
- ÀÛ¼ºÀÏ
- 2009-03-09
- Á¶È¸
- 6203
´ëÇÑÇ÷¾×ÇÐȸ ´Ù¹ß¼º °ñ¼öÁ¾ ¿¬±¸È¸´Â ¿À´Â 3¿ù 21ÀÏ (Åä) ½Å¶óÈ£ÅÚ ¿µºó°ü¿¡¼ Á¦ 5ȸ ASH Myeloma
Review¸¦ °³ÃÖÇÕ´Ï´Ù.
ÀÌ ÀÚ¸®¿¡¼´Â ÀÌŸ®ÀÇ Àú¸íÇÑ ÇÐÀÚÀÎ Dr. BoccadoroÀÇ ´Ù¹ß¼º°ñ¼öÁ¾ÃֽŠÁö°ß¿¡ ´ëÇÑ Æ¯°°ú ¿µ±¹ÀÇ Dr.HobbsÀÇ free light chainÀÇ ÃֽŠÁö°ß¿¡ ´ëÇÑ Æ¯°µµ ÁغñµÇ¾î ÀÖ½À´Ï´Ù.
³¯Â¥ : 2009³â 3¿ù 21ÀÏ (Åä)
½Ã°£ : ¿ÀÀü 10½Ã~ ¿ÀÈÄ 3:30ºÐ
Àå¼Ò : ½Å¶óÈ£ÅÚ ¿µºó°ü
Agenda
Session 1 Chairman: ¹Ú¼±¾ç ±³¼ö(¼¿ïÀÇ´ë), ÀÌÀçÈÆ ±³¼ö(°¡ÃµÀÇ´ë)
10:00 ~ 10:25 Pathophysiology and pre-clinical studies--¹ÚÇö°æ ±³¼ö(¼¿ïÀÇ´ë)
10:25 ~ 10:30 Discussion
10:30 ~ 10:55 Frontline treatment for non-transplantation candidates--¹®¿µÃ¶ ±³¼ö(ÀÌÈÀÇ´ë)
10:55~11:00 Discussion
11:00 ~ 11:25 Frontline treatment for Transplantation candidates 1--ÀÌÇö±Ô ±³¼ö(ÀÎÇÏÀÇ´ë)
11:25 ~ 11:50 Frontline treatment for Transplantation candidates 2--¹®ÁØÈ£ ±³¼ö(°æºÏÀÇ´ë)
11:50 ~ 12:00 Discussion
12:00 ~ 12:30 Lunch Break
Session 2 Chairman: ±èȿö ±³¼ö(¾ÆÁÖÀÇ´ë), À̵¿¼ø ±³¼ö(¼¿ïÀÇ´ë)
12:30 ~ 13:00 Dr.Boccadoro (Italy) : Recent advances in the treatment of Multiple Myeloma
13:00 ~ 13:10 Discussion
13:10 ~ 13:40 Dr. Hobbs (UK): Applications of serum free light chain assays
13:40 ~ 13:50 Discussion
13:50 ~ 14:00 Break
Session 3. Chairman:Á¶°æ»ï ±³¼ö(°æÈñÀÇ´ë), À±¼º¼ö ±³¼ö(¼¿ïÀÇ´ë)
14:00 ~ 14:25 Treatment for Relapsed/ Refractory disease--±èº´¼ö ±³¼ö(¼¿ïÀÇ´ë)
14:25 ~ 14:30 Discussion
14:30 ~ 14:55 Treatment for High Risk Patients, Cytogenetic Risk Factors, Renal impairment--¿À¼®Áß ±³¼ö(¼º±Õ°üÀÇ´ë)
14:55 ~ 15:00 Discussion
15:00 ~ 15:25 The role of Cyclophosphamide in the treatment of MM--ÀÌÀ±¾Æ ±³¼ö(Ä«Å縯ÀÇ´ë)
15:25 ~ 15:30 Discussion